Zobrazeno 1 - 10
of 108
pro vyhledávání: '"JM McLaughlin"'
Autor:
C Hyams, R Challen, E Begier, J Southern, J King, A Morley, Z Szasz-Benczur, M Garcia Gonzalez, J Kinney, J Campling, S Gray, J Oliver, R Hubler, SR Valluri, A Vyse, L Jodar, JM McLaughlin, G Ellsbury, N Maskell, BD Gessner, L Danon, A Finn
Publikováno v:
‘Outbreak!’ – COVID-19 epidemiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::669c75159c6dbf6ed0de8ad801744741
https://doi.org/10.1136/thorax-2022-btsabstracts.47
https://doi.org/10.1136/thorax-2022-btsabstracts.47
Autor:
C Hyams, R Challen, R Marlow, JL Nguyen, E Begier, J Southern, A Morley, J King, J Kinney, M Clout, J Oliver, G Ellsbury, N Maskell, L Jodar, BD Gessner, JM McLaughlin, L Danon, A Finn
Publikováno v:
‘Outbreak!’ – COVID-19 epidemiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adfcfbc154abfdbfa8b91bea03ce1172
https://doi.org/10.1136/thorax-2022-btsabstracts.44
https://doi.org/10.1136/thorax-2022-btsabstracts.44
Autor:
Nguyen JL; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Mitratza M; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium., Volkman HR; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., de Munter L; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium., Tran TMP; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium., Marques C; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Mustapha M; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Valluri S; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Yang J; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Antón A; Microbiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo del Valle de Hebrón 119-129, Barcelona 08035, Spain., Casas I; Hospital Universitari Germans Trias i Pujol, Carretera del Canyet, Badalona, Barcelona 08916, Spain., Conde-Sousa E; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium., Drikite L; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium., Grüner B; University Hospital Ulm, Division of Infectious Diseases, Department of Internal Medicine III, Alber-Einstein-Allee 23, Ulm 89081, Germany., Icardi G; Centro Interuniversitario per la Ricerca sull'Influenza e le altre Infezioni Trasmissibili - IRCCS Policlinico San Martino Hospital, Largo Benzi 10, Genoa 16132, Italy., Ten Kate GL; Universitair Ziekenhuis Antwerpen, Drie Eikenstraat 655, Edegem 2650, Belgium., Martin C; Le Centre Hospitalier Universitaire St Pierre, Rue Haute 322, Brussels 1000, Belgium., Mira-Iglesias A; Vaccine Research Department, Fisabio - Public Health, Avda. Cataluña 21, Valencia 46020, Spain.; Biomedical Research Consortium of Epidemiology and Public Health (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain., Orrico-Sánchez A; Vaccine Research Department, Fisabio - Public Health, Avda. Cataluña 21, Valencia 46020, Spain.; Biomedical Research Consortium of Epidemiology and Public Health (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain., Otero-Romero S; Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo del Valle de Hebrón 119-129, Barcelona 08035, Spain.; Centro de Esclerosis Múltiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo del Valle de Hebrón 119-129, Barcelona 08035, Spain., Rohde G; Goethe University Frankfurt, University Hospital, Medical Clinic I, Department of Respiratory Medicine, Theodor-Stern-Kai 7, Frankfurt/Main 60590, Germany., Jodar L; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., McLaughlin JM; Pfizer Inc., 66 Hudson Blvd. E., New York, NY 10001, United States., Bollaerts K; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 Dec 09; Vol. 79, pp. 102995. Date of Electronic Publication: 2024 Dec 09 (Print Publication: 2025).
Autor:
Tartof SY; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Frankland TB; Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, Hawaii., Puzniak L; Pfizer Inc, New York, New York., Slezak JM; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Ackerson BK; Southern California Permanente Medical Group, Harbor City, California., Hong V; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Stern J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Zamparo JM; Pfizer Inc, New York, New York., Chowdhry H; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Spence B; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Davis GS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California., Jodar L; Pfizer Inc, New York, New York., McLaughlin JM; Pfizer Inc, New York, New York.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Dec 02; Vol. 7 (12), pp. e2449944. Date of Electronic Publication: 2024 Dec 02.
Autor:
Caffrey AR; Infectious Diseases Research Program, Providence Veterans Affairs Healthcare System, Providence, RI, USA. Aisling_Caffrey@uri.edu.; Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Healthcare System, Providence, RI, USA. Aisling_Caffrey@uri.edu.; College of Pharmacy, University of Rhode Island, Kingston, RI, USA. Aisling_Caffrey@uri.edu.; School of Public Health, Brown University, Providence, RI, USA. Aisling_Caffrey@uri.edu., Appaneal HJ; Infectious Diseases Research Program, Providence Veterans Affairs Healthcare System, Providence, RI, USA.; Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Healthcare System, Providence, RI, USA.; College of Pharmacy, University of Rhode Island, Kingston, RI, USA., Lopes VV; Infectious Diseases Research Program, Providence Veterans Affairs Healthcare System, Providence, RI, USA., Puzniak L; Pfizer Inc. New York, New York, USA., Zasowski EJ; Pfizer Inc. New York, New York, USA., Jodar L; Pfizer Inc. New York, New York, USA., LaPlante KL; Infectious Diseases Research Program, Providence Veterans Affairs Healthcare System, Providence, RI, USA.; Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Healthcare System, Providence, RI, USA.; College of Pharmacy, University of Rhode Island, Kingston, RI, USA., McLaughlin JM; Pfizer Inc. New York, New York, USA.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 02; Vol. 15 (1), pp. 9490. Date of Electronic Publication: 2024 Nov 02.
Autor:
Volkman HR; Pfizer Inc., New York, NY 10001, USA., Nguyen JL; Pfizer Inc., New York, NY 10001, USA., Mustapha MM; Pfizer Inc., New York, NY 10001, USA., Jodar L; Pfizer Inc., New York, NY 10001, USA., McLaughlin JM; Pfizer Inc., New York, NY 10001, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Oct 17; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 17.
Autor:
Volkman HR; Pfizer Inc., 66 Hudson Blvd. E, New York, NY, 10001, USA. hannah.volkman@pfizer.com., Nguyen JL; Pfizer Inc., 66 Hudson Blvd. E, New York, NY, 10001, USA., Jodar L; Pfizer Inc., 66 Hudson Blvd. E, New York, NY, 10001, USA., McLaughlin JM; Pfizer Inc., 66 Hudson Blvd. E, New York, NY, 10001, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Oct; Vol. 13 (10), pp. 2203-2206. Date of Electronic Publication: 2024 Aug 24.
Autor:
Rodrigues CO; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Rosa RG; Internal Medicine Department, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil. Electronic address: regisgoulartrosa@gmail.com., Falavigna M; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., de Souza EM; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Manfio JL; Research Institute, HMV, Porto Alegre, RS, Brazil., de Souza AP; Research Institute, HMV, Porto Alegre, RS, Brazil., de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil., Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil; Federal University of Rio Grande do Sul (UFRGS), Brazil., Barbosa GRGDV; Research Institute, HMV, Porto Alegre, RS, Brazil., Silva FKR; Research Institute, HMV, Porto Alegre, RS, Brazil., Sganzerla D; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva MMD; Research Institute, HMV, Porto Alegre, RS, Brazil., Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil., Kunkel NT; Research Institute, HMV, Porto Alegre, RS, Brazil., Camargo NI; Research Institute, HMV, Porto Alegre, RS, Brazil., Sarturi JC; Research Institute, HMV, Porto Alegre, RS, Brazil., Guilhem MC; Research Institute, HMV, Porto Alegre, RS, Brazil., de Oliveira JC; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Lopes CC; Research Institute, HMV, Porto Alegre, RS, Brazil., Widmar F; Research Institute, HMV, Porto Alegre, RS, Brazil., Barufi LK; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva GN; Research Institute, HMV, Porto Alegre, RS, Brazil., Gradia DF; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Brandalize APC; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Royer CA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Luiz RM; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Baura VA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Abreu H; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Poitevin CG; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Kucharski GA; Department of Health of Toledo, Toledo, PR, Brazil., Pedrotti F; Department of Health of Toledo, Toledo, PR, Brazil., Valluri SR; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA; Orbital Therapeutics, Cambridge MA, USA., Julião VW; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Melone OC; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Allen KE; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Castillo GDCM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.
Publikováno v:
Immunology letters [Immunol Lett] 2024 Oct; Vol. 269, pp. 106903. Date of Electronic Publication: 2024 Jul 26.
Autor:
Rudolph AE; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA, 19426, USA. Abby.Rudolph@pfizer.com., Khan FL; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA, 19426, USA., Singh TG; Walgreens Co., Deerfield, IL, USA., Valluri SR; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA, 19426, USA., Puzniak LA; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA, 19426, USA., McLaughlin JM; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA, 19426, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Sep; Vol. 13 (9), pp. 2035-2052. Date of Electronic Publication: 2024 Aug 03.
Autor:
Weber DJ; Division of Infectious Diseases, UNC School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA., Zimmerman KO; Duke Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA., Tartof SY; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91107, USA., McLaughlin JM; Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA 19426, USA., Pather S; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Aug 29; Vol. 12 (9). Date of Electronic Publication: 2024 Aug 29.